PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
21.75%
Some net income increase while AVGO is negative at -1150.00%. John Neff would see a short-term edge over the struggling competitor.
-2.62%
Negative yoy D&A while AVGO is 0.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-7.04%
Negative yoy deferred tax while AVGO stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-6.52%
Negative yoy SBC while AVGO is 66.67%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
56.25%
Less working capital growth vs. AVGO's 168.75%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
183.87%
AR growth while AVGO is negative at -214.29%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-62.26%
Both reduce yoy inventory, with AVGO at -350.00%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
No Data
No Data available this quarter, please select a different quarter.
-140.58%
Negative yoy usage while AVGO is 211.76%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
255.56%
Some yoy increase while AVGO is negative at -50.00%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
20.02%
Operating cash flow growth below 50% of AVGO's 48.39%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-92.92%
Both yoy lines negative, with AVGO at -75.00%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
5.01%
Purchases growth of 5.01% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
300.00%
Liquidation growth of 300.00% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
31.47%
We have mild expansions while AVGO is negative at -75.00%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
11.76%
Issuance growth of 11.76% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-40.24%
We cut yoy buybacks while AVGO is 100.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.